Previous Page  12 / 20 Next Page
Information
Show Menu
Previous Page 12 / 20 Next Page
Page Background

Page 50

Notes:

Journal of Gastrointestinal & Digestive System | ISSN: 2161-069X | Volume: 8

&

&

October 29-30, 2018 | San Francisco, USA

International Conference on

Gastrointestinal Cancer and Therapeutics

4

th

World Congress on

Digestive & Metabolic Diseases

26

th

Annual Congress on

Cancer Science and Targeted Therapies

Apolipoprotein E mimetics dramatically reduce plasma cholesterol levels in several animal models

A

nalogous to apolipoprotein (apo) E, apoE mimetic peptide is a dual domain peptide, containing receptor binding domain

from apoE (LRKLRKRLLR, [hE], residues 141-150), linked to 18A the lipid-associating peptide. The resulting peptide,

Ac-hE18A-NH

2

, reduces plasma cholesterol in several animal models and possess anti-inflammatory properties which are

independent of the effect on plasma cholesterol. To enhance the cholesterol-reducing ability, we synthesized several analogs

of this peptide with fatty acyl chains of different length to LRRLRRRLLR-18A-NH

2

([R]hE18A-NH

2

) to produce Ac-Aha-[R]

hE18A-NH

2

, Octanyl-, Oleyl-, Palmityl- and Myristyl-[R]hE18A-NH

2

. The modified peptides were much more effective in

reducing plasma cholesterol in apoE null mice. Myristyl-peptide analog was the most effective. This analog was also most

effective in apoE null mice fed a Western diet, capable of reducing plasma cholesterol from 900mg/dL to almost undetectable

amount of plasma cholesterol in 5h. Plasma cholesterol levels in cynomolgus monkeys fed a Western diet was reduced by the

Myristyl-analog in a dose-dependent manner. A single dose maintained plasma cholesterol and low-density lipoprotein (LDL)

levels below baseline even after one week. However, plasma HDL levels were increased compared to baseline levels. Considering

the peptide Ac-hE18A-NH

2

has undergone Phase 1 clinical trials in humans, the new and highly active analogs are expected to

exhibit enhanced potency with lower doses in humans.

Biography

GM Anantharamaiah is a Professor in the Department of Medicine. He received his BS degree in 1967 from Bangalore University, India and his MS degree in 1969

from Bangalore University, as well. He completed his PhD degree in 1978. He has published more than 190 research papers and has several patents to his credit.

ananth@uab.edu

G M Anantharamaiah

University of Alabama at Birmingham, USA

G M Anantharamaiah, J Gastrointest Dig Syst 2018, Volume 8

DOI: 10.4172/2161-069X-C8-084